Literature DB >> 25855876

Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.

Jack X Q Pang, Erin Ross, Meredith A Borman, Scott Zimmer, Gilaad G Kaplan, Steven J Heitman, Mark G Swain, Kelly Burak, Hude Quan, Robert P Myers.   

Abstract

BACKGROUND: Severe alcoholic hepatitis (AH) is associated with a substantial risk for short-term mortality.
OBJECTIVES: To identify prognostic factors and validate well-known prognostic models in a Canadian population of patients hospitalized for AH.
METHODS: In the present retrospective study, patients hospitalized for AH in Calgary, Alberta, between January 2008 and August 2012 were included. Stepwise logistic regression models identified independent risk factors for 90-day mortality, and the discrimination of prognostic models (Model for End-stage Liver Disease [MELD] and Maddrey discriminant function [DF]) were examined using areas under the ROC curves.
RESULTS: A total of 122 patients with AH were hospitalized during the study period; the median age was 49 years (interquartile range [IQR] 42 to 55 years) and 60% were men. Median MELD score and Maddrey DF on admission were 21 (IQR 18 to 24) and 45 (IQR 26 to 62), respectively. Seventy-three percent of patients received corticosteroids and⁄or pentoxifylline, and the 90-day mortality was 17%. Independent predictors of mortality included older age, female sex, international normalized ratio, MELD score and Maddrey DF (all P<0.05). For discrimination of 90-day mortality, the areas under the ROC curves of the prognostic models (MELD 0.64; Maddrey DF 0.68) were similar (P>0.05). At optimal cut-offs of ≥22 for MELD score and ≥37 for Maddrey DF, both models excluded death with high certainty (negative predictive values 90% and 96%, respectively).
CONCLUSIONS: In patients hospitalized for AH, well-known prognostic models can be used to predict 90-day mortality, particularly to identify patients with a low risk for death.

Entities:  

Mesh:

Year:  2015        PMID: 25855876      PMCID: PMC4399372          DOI: 10.1155/2015/814827

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  33 in total

Review 1.  Sex difference in alcohol-related organ injury.

Authors:  N Sato; K O Lindros; E Baraona; K Ikejima; E Mezey; H A Järveläinen; V A Ramchandani
Journal:  Alcohol Clin Exp Res       Date:  2001-05       Impact factor: 3.455

Review 2.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

3.  A histologic scoring system for prognosis of patients with alcoholic hepatitis.

Authors:  José Altamirano; Rosa Miquel; Aezam Katoonizadeh; Juan G Abraldes; Andrés Duarte-Rojo; Alexandre Louvet; Salvador Augustin; Rajeshwar P Mookerjee; Javier Michelena; Thomas C Smyrk; David Buob; Emmanuelle Leteurtre; Diego Rincón; Pablo Ruiz; Juan Carlos García-Pagán; Carmen Guerrero-Marquez; Patricia D Jones; A Sidney Barritt; Vicente Arroyo; Miquel Bruguera; Rafael Bañares; Pere Ginès; Juan Caballería; Tania Roskams; Frederik Nevens; Rajiv Jalan; Philippe Mathurin; Vijay H Shah; Ramón Bataller
Journal:  Gastroenterology       Date:  2014-01-15       Impact factor: 22.682

4.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Authors:  M Malinchoc; P S Kamath; F D Gordon; C J Peine; J Rank; P C ter Borg
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

5.  The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations.

Authors:  Jack X Q Pang; Faruq Pradhan; Scott Zimmer; Sophia Niu; Pam Crotty; Jenna Tracey; Christopher Schneider; Steven J Heitman; Gilaad G Kaplan; Mark G Swain; Robert P Myers
Journal:  Can J Gastroenterol Hepatol       Date:  2014-03

6.  Hospital performance reports based on severity adjusted mortality rates in patients with cirrhosis depend on the method of risk adjustment .

Authors:  Robert P Myers; James N Hubbard; Abdel Aziz M Shaheen; Elijah Dixon; Gilaad G Kaplan
Journal:  Ann Hepatol       Date:  2012 Jul-Aug       Impact factor: 2.400

7.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

8.  Comparison of Maddrey Discriminant Function, Child-Pugh Score and Glasgow Alcoholic Hepatitis Score in predicting 28-day mortality on admission in patients with acute hepatitis.

Authors:  S Ali; S Hussain; M Hair; A A Shah
Journal:  Ir J Med Sci       Date:  2012-04-28       Impact factor: 1.568

9.  Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study.

Authors:  Robert P Myers; Abdel Aziz M Shaheen; Andrew Fong; Kelly W Burak; Alex Wan; Mark G Swain; Robert J Hilsden; Lloyd Sutherland; Hude Quan
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

10.  Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.

Authors:  Jack X Q Pang; Scott Zimmer; Sophia Niu; Pam Crotty; Jenna Tracey; Faruq Pradhan; Abdel Aziz M Shaheen; Carla S Coffin; Steven J Heitman; Gilaad G Kaplan; Mark G Swain; Robert P Myers
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

View more
  5 in total

1.  A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice.

Authors:  Michael Schonfeld; Maura O'Neil; Maria T Villar; Antonio Artigues; Janice Averilla; Sumedha Gunewardena; Steven A Weinman; Irina Tikhanovich
Journal:  Alcohol Clin Exp Res       Date:  2021-09-29       Impact factor: 3.928

2.  Hepatocyte PRMT1 protects from alcohol induced liver injury by modulating oxidative stress responses.

Authors:  Jie Zhao; Abby Adams; Steven A Weinman; Irina Tikhanovich
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

Review 3.  Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Authors:  Khushboo S Gala; Vatsalya Vatsalya
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

4.  Male-Specific Activation of Lysine Demethylases 5B and 5C Mediates Alcohol-Induced Liver Injury and Hepatocyte Dedifferentiation.

Authors:  Michael Schonfeld; Janice Averilla; Sumedha Gunewardena; Steven A Weinman; Irina Tikhanovich
Journal:  Hepatol Commun       Date:  2022-01-27

5.  Alcohol-associated fibrosis in females is mediated by female-specific activation of lysine demethylases KDM5B and KDM5C.

Authors:  Michael Schonfeld; Janice Averilla; Sumedha Gunewardena; Steven A Weinman; Irina Tikhanovich
Journal:  Hepatol Commun       Date:  2022-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.